PetCaseFinder

Peer-reviewed veterinary case report

Long-lasting blood clotting problems in dogs bitten by European adders

By Harjen, Hannah J et al.Ā·Published in PloS oneĀ·2022Ā·Faculty of Veterinary MedicineĀ·View original on PubMed →

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Persistent hypercoagulability in dogs envenomated by the European adder (Vipera berus berus).

Species:
dog

Plain-English summary

A group of dogs that were bitten by a European adder (Vipera berus berus) showed signs of increased blood clotting, known as hypercoagulability, which lasted for up to 15 days after the bite. The study found that dogs treated with antivenom had less severe hypercoagulability compared to those that did not receive the treatment. This suggests that getting antivenom may help reduce the risk of complications from the snake bite. Monitoring blood clotting levels can be an important part of managing dogs that have been envenomated.

People also search for: dog snake bite treatment Ā· European adder venom effects Ā· dog blood clotting after snake bite

Abstract

BACKGROUND: Envenomation by the European adder, Vipera berus berus (Vbb), is a medical emergency. The overall in vivo haemostatic effects of pro- and anticoagulant components in Vbb venom, and the downstream effects of cellular injury and systemic inflammation, are unclear. OBJECTIVES: To longitudinally describe the global coagulation status of dogs after Vbb envenomation and compare to healthy controls. A secondary aim was to investigate differences between dogs treated with and without antivenom. METHODS: Citrated plasma was collected at presentation, 12 hours (h), 24 h, 36 h and 15 days after bite from 28 dogs envenomated by Vbb, and from 28 healthy controls at a single timepoint. Thrombin generation (initiated with and without exogenous phospholipids and tissue factor), thrombin-antithrombin (TAT)-complexes and the procoagulant activity of phosphatidylserine (PS)-expressing extracellular vesicles (EVs), expressed as PS-equivalents, were measured. RESULTS: At presentation the envenomated dogs were hypercoagulable compared to controls, measured as increased thrombin generation, TAT-complexes and PS-equivalents. The hypercoagulability decreased gradually but compared to controls thrombin generation and PS-equivalents were still increased at day 15. The discrepancy in peak thrombin between envenomated dogs and controls was greater when the measurement was phospholipid-dependent, indicating that PS-positive EVs contribute to hypercoagulability. Lag time was shorter in non-antivenom treated dogs, compared to antivenom treated dogs <24 h after envenomation. CONCLUSIONS: Hypercoagulability was measured in dogs up to 15 days after Vbb envenomation. Dogs treated with antivenom may be less hypercoagulable than their non-antivenom treated counterparts. Thrombin generation is a promising diagnostic and monitoring tool for Vbb envenomation.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/35180240/